By Mike Ward
Editor, Europe
OXFORD - In a bid to win back some of its lost credibility, the U.K. biotech sector has unveiled its proposals for a voluntary code of practice to assist companies in their dealings with the financial community. Although the U.K. BioIndustry Association has been drafting the code for more than six months and identified nine principles of best practice, the document basically calls on companies to get the best advice they can get, appoint board members with something useful to contribute, and always tell the truth